35 related articles for article (PubMed ID: 9551920)
1. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine.
Thomson AW; Woo J; Lemster B; Todo S; Fung JJ; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):704-5. PubMed ID: 8438446
[No Abstract] [Full Text] [Related]
2. A mesoporous superparamagnetic iron oxide nanoparticle as a generic drug delivery system for tumor ferroptosis therapy.
Yang J; Xiong W; Huang L; Li Z; Fan Q; Hu F; Duan X; Fan J; Li B; Feng J; Xu Y; Chen X; Shen Z
J Nanobiotechnology; 2024 Apr; 22(1):204. PubMed ID: 38658948
[TBL] [Abstract][Full Text] [Related]
3. Selective vulnerability of human-induced pluripotent stem cells to dihydroorotate dehydrogenase inhibition during mesenchymal stem/stromal cell purification.
Al-Akashi Z; Zujur D; Kamiya D; Kato T; Kondo T; Ikeya M
Front Cell Dev Biol; 2023; 11():1089945. PubMed ID: 36814599
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression.
Colligan SH; Amitrano AM; Zollo RA; Peresie J; Kramer ED; Morreale B; Barbi J; Singh PK; Yu H; Wang J; Opyrchal M; Sykes DB; Nemeth MJ; Abrams SI
J Clin Invest; 2022 Dec; 132(23):. PubMed ID: 36453551
[TBL] [Abstract][Full Text] [Related]
5. Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated
Carrau L; Rezelj VV; Noval MG; Levi LI; Megrian D; Blanc H; Weger-Lucarelli J; Moratorio G; Stapleford KA; Vignuzzi M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270226
[TBL] [Abstract][Full Text] [Related]
6. Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.
Cao L; Weetall M; Trotta C; Cintron K; Ma J; Kim MJ; Furia B; Romfo C; Graci JD; Li W; Du J; Sheedy J; Hedrick J; Risher N; Yeh S; Qi H; Arasu T; Hwang S; Lennox W; Kong R; Petruska J; Moon YC; Babiak J; Davis TW; Jacobson A; Almstead NG; Branstrom A; Colacino JM; Peltz SW
Mol Cancer Ther; 2019 Jan; 18(1):3-16. PubMed ID: 30352802
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic Mitochondrial Dysfunction as a Target in Obesity and Metabolic Disease.
Cunarro J; Casado S; Lugilde J; Tovar S
Front Endocrinol (Lausanne); 2018; 9():283. PubMed ID: 29904371
[TBL] [Abstract][Full Text] [Related]
8. Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.
Nair S; Poddar S; Shimak RM; Diamond MS
J Virol; 2017 Nov; 91(22):. PubMed ID: 28835505
[TBL] [Abstract][Full Text] [Related]
9. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.
Peters GJ; Schwartsmann G; Nadal JC; Laurensse EJ; van Groeningen CJ; van der Vijgh WJ; Pinedo HM
Cancer Res; 1990 Aug; 50(15):4644-9. PubMed ID: 2164443
[TBL] [Abstract][Full Text] [Related]
11. Brequinar sodium: monitoring immunosuppressive activity.
Eiras-Hreha G; Cramer DV; Cosenza C; Chapman FA; Mills L; Cajulis E; Hill D; Jones E; Zajac I; Jaffee B
Transplant Proc; 1993 Jun; 25(3 Suppl 2):32-6. PubMed ID: 8516940
[TBL] [Abstract][Full Text] [Related]
12. Brequinar sodium.
Cramer DV
Transplant Proc; 1996 Apr; 28(2):960-3. PubMed ID: 8623481
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium.
Xu X; Williams JW; Shen J; Gong H; Yin DP; Blinder L; Elder RT; Sankary H; Finnegan A; Chong AS
J Immunol; 1998 Jan; 160(2):846-53. PubMed ID: 9551920
[TBL] [Abstract][Full Text] [Related]
14. Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.
Xu X; Gong H; Blinder L; Shen J; Williams JW; Chong AS
J Pharmacol Exp Ther; 1997 Nov; 283(2):869-75. PubMed ID: 9353408
[TBL] [Abstract][Full Text] [Related]
15. The antilymphocytic activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production.
Woo J; Lemster B; Tamura K; Starzl TE; Thomson AW
Transplantation; 1993 Aug; 56(2):374-81. PubMed ID: 8356593
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]